Amcor plc (ASX:AMC)
Australia · Delayed Price · Currency is AUD | Market Cap | 30.43B +9.6% |
| Revenue (ttm) | 34.35B +37.3% |
| Net Income | 1.56B +86.6% |
| EPS | 3.39 +45.3% |
| Shares Out | n/a |
| PE Ratio | 19.19 |
| Forward PE | 10.97 |
| Dividend | 3.50 (5.39%) |
| Ex-Dividend Date | Nov 24, 2026 |
| Volume | 1,431,979 |
| Open | 65.50 |
| Previous Close | 62.11 |
| Day's Range | 64.97 - 65.95 |
| 52-Week Range | 51.20 - 71.10 |
| Beta | 0.58 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About Amcor
Amcor plc, together with its subsidiaries, develops and produces packaging solutions for nutrition, health, beauty, and wellness categories in Europe, North America, Latin America, and the Asia Pacific. Its products include apparel, applicators, bags and bulk bags, bottles and vials, building materials, canisters and jerrycans, drinking cups, films and laminates, jars, lids, tapes and adhesives, trays, tubes, wipes packaging solutions, and miscellaneous and accessories, as well as tubs and pots. The company’s Global Flexible Packaging Solutions... [Read more]
Financial Performance
In fiscal year 2026, Amcor's revenue was $23.51 billion, an increase of 56.61% compared to the previous year's $15.01 billion. Earnings were $1.11 billion, an increase of 116.86%.
Financial numbers in USD Financial StatementsNews
Amcor price target raised to $49 from $47 at BofA
BofA raised the firm’s price target on Amcor (AMCR) to $49 from $47 and keeps a Buy rating on the shares.
Amcor Quarterly report: Q3 2026
Amcor has published its Q3 2026 quarterly earnings report on November 5, 2026.
Amcor downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Amcor (AMCR) to Hold from Buy with a price target of $45, down from $50. While the company showed continued progress on organic growth and synergy realization…
Amcor downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Hillary Cacanando downgraded Amcor (AMCR) to Hold from Buy.
Amcor Earnings Call Transcript: Q1 2027
Organic volumes rose 1%, with focus categories up 3%, while adjusted EPS was $0.95. Higher energy and distribution costs lowered transition-period EPS guidance; 2027 growth and synergy targets remain intact.
Amcor Earnings release: Q1 2027
Amcor released its Q1 2027 earnings on November 4, 2026, summarizing the period's financial results.
Amcor Slides: Q1 2027
Amcor has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on November 4, 2026.
Amcor reports Q3 adjusted EPS 95c, consensus 99c
Reports Q3 revenue $6.13B, consensus $5.75B. Amcor (AMCR) CEO Peter Konieczny said, “We delivered solid operating results this quarter, with broad-based organic volume growth of 1%, led by 3% volume…
Amcor board increases quarterly dividend 1c to 66c per share
16:23 EST Amcor (AMCR) board increases quarterly dividend 1c to 66c per share
Amcor lowers ‘transition period’ adjusted EPS view to $1.70-$1.80
Amcor (AMCR) will have a six-month reporting period from July 1, 2026, through December 31, 2026, as part of transitioning from a previously announced June 30 to December 31 year-end.
Amcor Reports Solid Results for Quarter ended September 30, 2026
Net sales of $6,129 million up 7% over prior-year Diluted EPS of $0.52; Adjusted Diluted EPS of $0.95 GAAP Net Income of $242 million Adjusted EBITDA $883 million, flat to prior year 1 Updates Outlook...
Amcor Proxy statement: Proxy filing
Amcor filed a proxy statement on November 3, 2026, providing details for shareholder voting and corporate governance matters.
Looking for income? These dividend stocks have high yields that seem well supported.
Ford, Pfizer and Verizon are among 11 stocks that passed a screen of the S&P 500 for high dividend yields that are expected to be well covered by the companies' free cash flow.
Amcor Proxy statement: Proxy filing
Amcor filed a proxy statement on October 28, 2026, providing details for shareholder voting and corporate governance matters.
Looking for High Yields? Dividend Aristocrat Stocks to Watch, According to Analysts
Dividend aristocrats continue to stand out for offering investors a steady stream of cash payouts. Hormel Foods ($HRL), Realty Income ($O), and Amcor ($AMCR) rank among the top five Dividend…
Amcor to report September 2026 results
ZURICH, Oct. 21, 2026 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its September 2026 results for the three month period ended September 30, 2026, after the US market closes on Wedne...
Amcor Proxy statement: Proxy filing
Amcor filed a proxy statement on October 8, 2026, providing details for shareholder voting and corporate governance matters.
Amcor price target lowered to $47 from $52 at BofA
BofA lowered the firm’s price target on Amcor (AMCR) to $47 from $52 and keeps a Buy rating on the shares as the firm adjusted targets among its packaging and…
Amcor Proxy statement: Proxy filing
Amcor filed a proxy statement on September 29, 2026, providing details for shareholder voting and corporate governance matters.
Amcor Proxy statement: Proxy filing
Amcor filed a proxy statement on September 29, 2026, providing details for shareholder voting and corporate governance matters.
Amcor chair Graeme Liebelt to retire, Tom Long elected to assume role
Amcor (AMCR) announced that Graeme Liebelt will not stand for re-election and will retire from the Company’s Board of Directors at the end of his current term as a director…
Amcor announces Board Chair transition
ZURICH, Sept. 29, 2026 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, announced today that Graeme Liebelt will not stand for...
Amcor Transcript: Jefferies Global Industrials Conference 2026
Integration synergies are ahead of schedule, supporting double-digit EPS growth and robust revenue synergies. Capital allocation focuses on organic growth, deleveraging, and targeted portfolio pruning, with private label and high-growth categories prioritized for expansion.
JPMorgan downgrades Amcor with divestitures slowing growth
JPMorgan downgraded Amcor (AMCR) to Neutral from Overweight with a price target of $47, up from $44. The company’s EBITDA growth is slowed by its divestiture agenda, the analyst tells…